TrialAnnals of the rheumatic diseases2023

Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies.

Walter Reinisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.